Cargando…
Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma
BACKGROUND: Tropomyosin 4 (TPM4), a member of the tropomyosin family, is aberrantly expressed and plays an important role in a variety of cancers. However, studies on TPM4 in glioma patients are currently lacking. OBJECTIVE: Our study aimed to evaluate the diagnostic and prognostic characteristics o...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837963/ https://www.ncbi.nlm.nih.gov/pubmed/36639743 http://dx.doi.org/10.1186/s12883-023-03058-0 |